Politico November 4, 2025
David Lim, Lauren Gardner

The administration, as well as HHS, publicly praised Marty Makary’s leadership despite persistent upheaval at the agency.

The White House is rallying behind Food and Drug Administration Commissioner Marty Makary after the abrupt ousting of one of his top deputies over the weekend, the latest tumult in an agency that’s seen plenty this year.

A new top drug regulator will likely be installed on Wednesday to replace George Tidmarsh as director of the FDA’s Center for Drug Evaluation and Research, according to a Health and Human Services official granted anonymity to discuss personnel planning.

That individual will not be Vinay Prasad, the controversial head of the FDA’s biologics center, in charge of vaccines, who also works as the agency’s chief...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: Congress / White House, FDA, Govt Agencies, HHS
AI Model FDA-Cleared to Triage 14 Conditions
The Promise And Perils Of FDA’s New ‘Plausible Mechanism’ Pathway (Part 2)
FDA Updates Two Digital Health Final Guidance Documents
FDA in Flux — January 2026 Newsletter
The Promise And Perils Of FDA’s New ‘Plausible Mechanism’ Pathway (Part 1)

Share Article